These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36854058)

  • 1. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts.
    Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
    Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.
    Risch HA; Yu H; Lu L; Kidd MS
    J Natl Cancer Inst; 2010 Apr; 102(7):502-5. PubMed ID: 20181960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis.
    Schulte A; Pandeya N; Fawcett J; Fritschi L; Risch HA; Webb PM; Whiteman DC; Neale RE
    Cancer Causes Control; 2015 Jul; 26(7):1027-35. PubMed ID: 25951801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.
    Huang J; Zagai U; Hallmans G; Nyrén O; Engstrand L; Stolzenberg-Solomon R; Duell EJ; Overvad K; Katzke VA; Kaaks R; Jenab M; Park JY; Murillo R; Trichopoulou A; Lagiou P; Bamia C; Bradbury KE; Riboli E; Aune D; Tsilidis KK; Capellá G; Agudo A; Krogh V; Palli D; Panico S; Weiderpass E; Tjønneland A; Olsen A; Martínez B; Redondo-Sanchez D; Chirlaque MD; Hm Peeters P; Regnér S; Lindkvist B; Naccarati A; Ardanaz E; Larrañaga N; Boutron-Ruault MC; Rebours V; Barré A; Bueno-de-Mesquita HB; Ye W
    Int J Cancer; 2017 Apr; 140(8):1727-1735. PubMed ID: 28032715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxin-Associated Gene A-Negative Strains of Helicobacter pylori as a Potential Risk Factor of Pancreatic Cancer: A Meta-Analysis Based on Nested Case-Control Studies.
    Chen XZ; Wang R; Chen HN; Hu JK
    Pancreas; 2015 Nov; 44(8):1340-4. PubMed ID: 26390415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
    Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
    Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori seropositivities and risk of pancreatic carcinoma.
    Risch HA; Lu L; Kidd MS; Wang J; Zhang W; Ni Q; Gao YT; Yu H
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):172-8. PubMed ID: 24234587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
    Parsonnet J; Friedman GD; Orentreich N; Vogelman H
    Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of
    Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
    Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
    Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N
    Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
    Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
    Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects.
    Simán JH; Engstrand L; Berglund G; Florén CH; Forsgren A
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):304-9. PubMed ID: 15699426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer.
    Stolzenberg-Solomon RZ; Blaser MJ; Limburg PJ; Perez-Perez G; Taylor PR; Virtamo J; Albanes D;
    J Natl Cancer Inst; 2001 Jun; 93(12):937-41. PubMed ID: 11416115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori seropositivity and risk of lung cancer.
    Koshiol J; Flores R; Lam TK; Taylor PR; Weinstein SJ; Virtamo J; Albanes D; Perez-Perez G; Caporaso NE; Blaser MJ
    PLoS One; 2012; 7(2):e32106. PubMed ID: 22384154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between seroprevalence of
    Khosravi AD; Sirous M; Saki M; Seyed-Mohammadi S; Modares Mousavi SR; Veisi H; Abbasinezhad Poor A
    J Int Med Res; 2021 Dec; 49(12):3000605211058870. PubMed ID: 34875914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.